We're now investing out of NFX Fund IV. Like you, we're operators and entrepreneurs. And we see what you're seeing: The world of technology is at a turning point.

NFX fellows are our representatives on campus. They’re the main contacts for our on-campus FAST funding competitions for student and alumni founders. (More on new FAST events coming soon) Learn more and get in touch with our fellows here:

We're excited to announce the 2026 NFX Fellows cohort! Our 21 fellows were carefully selected from an application pool of 300+ students from Harvard, Stanford, MIT, and UC Berkeley. This is an exceptionally talented group with a wide range of experience.

Here's what we saw in them on day 0: https://t.co/1sR1qq16Cy

Congratulations to Cyclana Bio on their £5M Pre-Seed round! We led the round alongside @eka_ventures. Cyclana Bio is building a full human tissue discovery platform to reveal how tissue and matrix biology drive chronic inflammatory disease —starting with endometriosis.

I want to share my new adventure with everyone. Along with my co-founder, @lea_md_wenger , we have started a company called Cyclana Bio. We just raised a £5M ($8M) pre-seed round to work towards a serious societal health problem, endometriosis.

NFX raises $325 million for new fund, Levy-Weiss predicts ‘a new wave of global giants’ from Israel. Venture firm @NFX closes its fourth fund as co-founder @GigiLevy sees opportunity in Israel’s maturing tech sector and AI boom. https://t.co/7HpELFSlst

If we invest, it’s because we believe you – specifically you – can go the distance. Here are the key details on Fund IV, like who we work with and what themes we're tracking:

Or read the full coverage of the round in @FortuneMagazine:

We're excited to have backed @evenuplaw from the very beginning. Congratulations to the team on their $150M Series E! Here's what we saw in them on day 0:

Read the full article from @omri_drory here -

We wanted to capture on video the importance of fundraising seasonality. Attention pools at certain times of year and decisions move faster in the hot windows. The best founders know how to use that rhythm to their advantage. The Seasons of Fundraising — new video ⬇️

https://t.co/8ixxhABraE

Without bio, AI utopia can't exist. AI will generate huge value, but achieving big goals — curing disease, halting climate change, extending life — requires merging AI with science. @omri_drory highlights the need for tech investors and bio founders to fulfill AI's potential ⬇️

Spots are filling up in our AI + Bio event. We'll cover where founders are finding traction, what investors look for, and more. 📍 NFX HQ, San Francisco 📅 Monday, Sept 22 ⏰ 6–9 PM PT Register here:

AI is everywhere in bio. But how much is real and how much is hype? We’re bringing founders + investors together to cut through the noise. 📍 NFX HQ, San Francisco 📅 Monday, Sept 22 ⏰ 6–9 PM PT Register here:

We're excited about the multiple tech windows opening in cyber – today and in the future. @GigiLevy describes the big ideas and how top teams are gaining fast traction in this space:

For decades, cybersecurity meant defending the OS perimeter. But today, the real threats live at the application layer: plugins, extensions, AI models, and code packages. The battleground has shifted. This shift creates a new windows for startups.

Congratulations to the team! Here's what we saw in them from day 0:

We're excited to invest in F2, an AI platform for private financial market investors alongside @ycombinator and @leftlanecap. F2 was spun out of @join_arc, one of our portfolio companies. They're out of stealth today, after 1yr of fine tuning to become enterprise-grade.